Diagnosis and Management of Hypertrophic CardiomyopathyISBN: 978-1-4051-1732-6
Hardcover
528 pages
April 2004, Wiley-Blackwell
This is a Print-on-Demand title. It will be printed specifically to fill your order. Please allow an additional 10-15 days delivery time. The book is not returnable.
|
Major purpose
To provide a single comprehensive source of information,
including differing viewpoints, concerning HCM as well as
cardiovascular disease in athletes - - - for clinical and research
cardiologists, primary care physicians, and basic scientists, and
written and assembled by all the experts in the field.
3 features
1. The book literally includes the contributions of all experts
in the field and therefore can be regarded as truly comprehensive,
taking into account sometimes diverse viewpoints regarding this
heterogeneous disease (i.e., HCM) and related issues in
athletes.
2. There is no other available source that comes remotely
close...so it is a novel undertaking.
3. Because there is so much misunderstanding regarding the
aforementioned issues in the physician community...and because
these are not clinical problems necessarily encountered on a daily
basis by most practicing physicians...this book becomes a
particularly important source to interested parties - - - i.e.,
information they may not be able to assemble easily in any other
way.
Recent advances of note
1. Use of implantable defibrillator in HCM for prevention of
sudden death in young people.
2. Introduction of catheter-based alcohol septal ablation to
reduce obstruction and symptoms as a treatment alternative to
surgery for some HCM patients.
3. Definition of the genetic basis for HCM and its role in
clinical diagnosis and risk stratification.
4. Development of more precise strategies for assessing the
level of risk for sudden death among all patients with HCM.
5. More precise definition of the relatively high frequency with
which HCM occurs in the general population.
Special emphasis
All of the above, plus: the septal myectomy operation remains the gold standard for the severely symptomatic patient with obstruction, refractory to medications.